Agreed, if you really have faith in a companies products and business model you'd be happy to see it trade, and if the market valued it at 25c you'd be even happier to buy more.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%